Back
Ascendis Pharma AS Stock Predictions
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
38
ASND
Ascendis Pharma AS
Last Price:
140.94
Seasonality Move:
7.62%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Ascendis Pharma AS Stock Forecast
- Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 32.4% based on the past 9 years of stock performance.
- Ascendis Pharma AS has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
-
Is Ascendis Pharma AS Stock Undervalued?
The current Ascendis Pharma AS [ASND] share price is $146.29. The Score for ASND is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Ascendis Pharma AS Stock Go Up Next Year?
- Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 32.4% based on the past 9 years of stock performance.
Ascendis Pharma AS Stock Rating
Sell
38
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS overpriced?
- Ascendis Pharma AS has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
Ascendis Pharma AS Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com
52-Week Data
52-Week High:
161.00
52-Week Low:
85.29
Prediction Charts
Market Cap:
8.74B
Price in USD:
146.29
Volume:
564.97K
Beta:
0.62
Technical Analysis
SMA50:
135.04
SMA100:
133.62
SMA200:
137.28
52-Wk Change:
60.53%
Stock Predictions
-
Is Ascendis Pharma AS stock public?
Yes, Ascendis Pharma AS is a publicly traded company. -
What is the Ascendis Pharma AS stock quote today?
The Ascendis Pharma AS stock price is 146.29 USD today. -
How to buy Ascendis Pharma AS stock online?
You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-13 | 116.29 | 119.22 | 119.49 | 114.53 |
| Sep-16 | 139.65 | 139.57 | 145.00 | 137.75 |
| Sep-17 | 140.24 | 146.59 | 148.92 | 138.82 |
| Sep-18 | 146.59 | 148.89 | 150.43 | 145.77 |
| Sep-19 | 151.00 | 153.43 | 154.81 | 149.26 |
| Sep-20 | 153.75 | 151.26 | 155.53 | 150.85 |
| Sep-23 | 151.48 | 146.60 | 151.87 | 145.72 |
| Sep-24 | 145.98 | 144.81 | 147.58 | 143.98 |
| Sep-25 | 144.78 | 146.27 | 149.56 | 144.73 |
| Sep-26 | 147.64 | 147.36 | 147.64 | 144.43 |
| Sep-27 | 147.01 | 144.62 | 148.31 | 142.98 |
| Sep-30 | 143.69 | 149.31 | 149.67 | 143.12 |
| Oct-1 | 149.31 | 146.68 | 149.31 | 144.12 |
| Oct-2 | 146.47 | 146.29 | 147.96 | 144.88 |
Ascendis Pharma AS Earnings
Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Ascendis Pharma AS Forecast Revenue Growth
Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.47 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.61 per share, and an increase next year of $4.43 per share.
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.